Hollister and Heavy Grass Collaborate with Slipknot Co-Founder Shawn “Clown” Crahan on New HashBone Line


Ryan Allway

May 17th, 2021

News


Crahan is a multi-platinum, Grammy-winning artist who has sold more than 30 million albums. Clown’s signature HashBone pre-roll packs will mark the first co-branded release from the Hollister-Heavy Grass licensing agreement. The products will initially be launched on May 17th in select dispensaries in California and on DreamyDelivery.com.

 

VANCOUVER, BCMay 17, 2021 /CNW/ – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) and Heavy Grass have partnered with Slipknot co-founder Shawn “Clown” Crahan for special-edition HashBone packs featuring six half-gram pre-rolls and matches in a soft-touch matte black case. The multi-platinum, Grammy-winning artist has sold more than 30 million records with Slipknot, whose last three albums debuted at No. 1 on both the Billboard 200 and the U.K. Albums Chart.

 

Branded with original artwork, Clown’s signature HashBone line contains a potent uplifting blend of 75% indica flower and 25% Paradise Citrus bubble hash. The signature premium indica flower features an earthy citrus-rich flavor profile with sublime sedating effects. Paradise Citrus, made from crossing Tropicana Cookies and Tina, adds another layer of full-body relaxation with happy head highs and citrusy notes of orchard-fresh sour orange. Lab testing confirms the potency of these hash-infused pre-rolls with THC levels above 40%.

 

Shawn “Clown” Crahan is a multi-talented artist who co-founded Slipknot, directed most of its music videos and serves as one of the primary songwriters. Clown is also the creative force behind Slipknot’s iconic visuals, originating the masks and uniforms, creating album covers, packaging, live staging and visuals, and all merchandise.

 

Heavy Grass is a California cannabis brand with deep roots in the hard rock and heavy metal music community. In 2020 (see press release dated July 28, 2020), Hollister entered into a licensing agreement with Heavy Grass to produce and sell co-branded cannabis products primarily through collaborations with its music partners. HashBone, a leading hash-infused pre-roll in California, is one of Hollister’s signature products, and the Clown HashBone line represents the first collaborative release between Hollister, Heavy Grass and one of its artists.

 

“We are very excited to be launching our HashBone collaboration with Clown. We couldn’t ask for a better partner and someone who is true to the plant. This partnership is our first step in combining hard rock/metal with cannabis in a truly authentic way,” says Carl Saling, the Co-Founder, CEO and Director of Hollister Biosciences. “Additionally, we are happy that we get to bring Clown to market in tandem with our friends at Heavy Grass – leveraging their experience in music-inspired cannabis products will amplify our overall marketing efforts.”

 

Clown, a long-time cannabis connoisseur, is also an advocate for its potential therapeutic benefits. He adds, “Just remember, it’s medicine.”

 

In celebration of the release of Clown Cannabis, Clown and Heavy Grass are offering a once in a lifetime Green Ticket experience. The winner of Clown’s Green Ticket will receive unlimited entrance for two into any Slipknot shows in the world for the next three years. For entry details visit theheavygrass.com.

 

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state company with a portfolio of innovative, high-quality cannabis & hemp branded consumer products and white-labeling manufacturing. Our products are sold in 370 dispensaries across Arizona and California. Hollister Biosciences wholly-owned brand, Venom Extracts, is a category-leading brand that sold more than 4 million grams in 2020, accounting for up to 30 percent of category sales in Arizona.

 

Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products and full-spectrum high CBD pet tinctures. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA, birthplace of the “American Biker”.

 

Website: www.hollisterbiosciences.cowww.hollistercannabisco.com
Instagram: @hashbones @hollistercannabisco

 

About Heavy Grass
Heavy Grass is a California cannabis brand that honors the legacy and lifestyle of heavy music by plugging in, getting loud and blazing up. We work with top California cultivators to provide both high quality and high potency products to our fans at an affordable price.  We want fans to spend money on a good time, not overpriced weed. www.theheavygrass.com | @heavygrassofficial

 

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

 

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

SOURCE Hollister Biosciences Inc.

For further information: HOLLISTER BIOSCIENCES INC.: Company Contact: Melanie Barbeau: [email protected], Tel: (416) 644-2020 or (212) 812-7680, www.renmarkfinancial.com

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading